Clinical Trial Update: Early Use of Rosuvastatin in Acute Coronary Syndromes: Targeting Platelet-Leukocyte Interactions [Phase 1]

View source ↗

Summary

Phase 1 trial assessing early administration of rosuvastatin in acute coronary syndrome to target platelet-leukocyte interactions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Susan Smyth | Conditions: Acute Coronary Syndrome, Angioplasty, Transluminal, Percutaneous Coronary | Phase 1 | Status: COMPLETED | Results posted: 2014-06-24